Aileron Therapeutics, Inc.
Peptidomimetic macrocycles and uses thereof
Last updated:
Abstract:
Methods for treating solid tumor, determined to lack a p53 deactivation mutation, in a subject are provided. Also provided are peptidomimetic macrocycles for use in treatment of a solid tumor, determined to lack a p53 deactivation mutation, in a subject.
Status:
Grant
Type:
Utility
Filling date:
24 Sep 2015
Issue date:
12 Nov 2019